Beaufort

Beaufort

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $5M

Overview

Beaufort is a specialized Contract Research Organization (CRO) serving the MedTech sector, including medical devices, in-vitro diagnostics (IVD), and digital health. The company leverages over 20 years of collective MedTech experience to offer a full suite of services from regulatory strategy and clinical trial management to submission support, emphasizing agility and precision. Its value proposition centers on deep therapeutic and technical expertise, a client-centric partnership model, and a proven track record of over 1,000 global clinical trials and 500+ regulatory submissions. Beaufort is a private, revenue-generating services firm catering to innovative technology companies seeking to bring novel healthcare solutions to market faster.

OncologyCardiovascularInfectious DiseaseWomen’s HealthUrologyNeurology

Technology Platform

Integrated suite of specialized clinical research and regulatory services tailored for the MedTech development lifecycle, including specific methodologies for medical devices, IVDs, and digital health technologies. Emphasis on agile, client-partnership models and deep domain expertise.

Funding History

1
Total raised:$5M
Seed$5M

Opportunities

Growing demand for specialized CRO services due to increasing complexity in MedTech, IVD, and digital health regulations.
The rise of AI, robotics, and personalized medicine creates a need for partners with technical and regulatory expertise that traditional pharma CROs lack, positioning Beaufort to capture market share.

Risk Factors

High competition from both large full-service CROs and other niche players.
Operational risk related to data integrity and regulatory compliance on client projects.
Dependency on client R&D spending cycles and potential vulnerability to economic downturns affecting the MedTech sector.

Competitive Landscape

Competes against large, diversified CROs (e.g., IQVIA, ICON) that have MedTech divisions and against other specialized, smaller MedTech CROs. Differentiation is based on deep sector-specific expertise, agile and flexible service models, and a partnership approach as an extension of the client's team.